Past Event

DEA Rescheduling: Navigating the Regulatory and Financial Changes for Cannabis Companies

  • Date & Time
  • Location

    Los Angeles, CA

    Washington, D.C

  • Event Type
    Webinar
  • Add to Calendar Disabled

ArentFox Schiff Partners Emily Leongini, Justin Goldberg, and moderator David Grosso discuss the potential implications of the DEA’s rescheduling proposal on cannabis companies around the country.

Click here to view the event recording.

The webinar covers key insights on what companies, investors, researchers and industry professionals can expect in the wake of DEA’s long-awaited, and eagerly anticipated, proposed rescheduling of cannabis.

Key Topics:

  1. Analysis of DEA’s proposed rule and likely next steps in the administrative process;
  2. Regulatory implications of cannabis becoming a Schedule III substance—what to expect from DEA, FDA, and states;
  3. Comprehensive analysis of financial trends and forecasts within the industry; and
  4. Essential legal considerations for cannabis businesses.

Contacts

Continue Reading